GSK4381562

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK4381562, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors [Phase 1]